Experience New York City like never before with the 2018 United Airlines NYC Half! Race through the streets of Times Square, catch beautiful views of the Hudson River from the west side highway, and finish at the iconic South Street Seaport. The 2018 United Airlines NYC Half provides you with an opportunity to transform lives in a direct and meaningful way.
DEGREGORIO FAMILY FOUNDATION (DFF)
This will be our 10th year a team of DFF supporters will be running the NYC Half Marathon. 100% of funds raised will go directly to research for stomach and esophageal cancers. With your help we can make a difference!
WHO WE ARE
Stomach and esophageal cancers are among the fastest growing and most underfunded cancers in the world. The DeGregorio Family Foundationseeks to fund innovative research focused on curing gastricand esophageal cancer. All funds raised go directly to providing grants to innovative researchers.
DFF was founded in 2006 after a tenth member of Lynn DeGregorio’s family succumbed to stomach cancer and was found to have possessed a rare gene that causes the disease and other common cancers. Lynn and her surviving sibling, who both tested negative for the gene, created the foundation to raise funds for research on the hereditary and non-hereditary varieties of stomach and esophageal cancer. Since its inception, the Foundation has made tremendous progress in providing the private support needed to learn more about these cancers, which affect millions of people annually around the globe.
Each year DFF’s Scientific Advisory Board, comprised of world renowned oncologists and scientists from institutions worldwide, review grant applications and award funds to applicants who are both innovative and will be a catalyst to collaboration. Each year DFF awards $250,000 in grants to promising researchers and clinical scientists worldwide whose work can make meaningful strides in gastric and esophageal cancer research.
You can join us in turning the deadly facts about stomach and esophageal cancer into fiction. Your support will promote education and facilitate research into these deadly diseases – and help us lead the way to effective treatments and, one day, a cure.